UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 19, 2022
Accession Number:
0001193125-22-058489
Submission Type:
POS AM
CIK:
0001382101
Company Name:
SUTRO BIOPHARMA, INC.
File Number:
333-255014